methylation
Previse Launches Esophageal Cancer Risk Test, Raises $3M to Support Commercial Expansion
The company hopes to build prospective clinical utility evidence for the Esopredict test, its first clinical assay, to support future reimbursement.
GenoMe Diagnostics Preparing Digital PCR-Based Ovarian Cancer Test for US, EU, UK Submissions
Premium
The Belfast, Northern Ireland-based company also believes its technology could be used to create other early-stage detection tests for multiple cancers.
The Canadian company plans to test the clinical utility of its targeted 90-marker panel in monitoring patient response to therapy.
TruDiagnostic, North Carolina State University Ink Licensing Deal for Methylation Microarray
The microarray examines imprint control regions of the genome to determine a patient's risk of developing certain diseases.
European Team Publishes Molecular Endometrial Cancer Test; Startup Sola Dx Plans Fall Launch
Premium
Called WID-qEC, the test uses quantitative PCR methylation profiling to diagnose endometrial cancer in women presenting with symptoms.